scholarly article | Q13442814 |
P50 | author | Lennart Minthon | Q66724775 |
Elisabet Londos | Q66724780 | ||
Carina Wattmo | Q92523170 | ||
P2093 | author name string | Elisabeth Paulsson | |
P2860 | cites work | Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment | Q51037244 |
Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment. | Q51558760 | ||
Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting. | Q51906755 | ||
Cognitive impairment, caregiver burden, and the utilization of home health services. | Q52016959 | ||
Assessment of older people: self-maintaining and instrumental activities of daily living | Q66829682 | ||
Predicting the Volume of Health and Social Services: Integrating Cognitive Impairment into the Modified Andersen Framework | Q67754245 | ||
The impact of female caregivers' employment status on patterns of formal and informal eldercare | Q74702709 | ||
The systems of care for frail elderly persons: the case of Sweden | Q78601808 | ||
Gender differences in use and availability of home and community-based services for people with dementia | Q81222761 | ||
Determinants of costs of care for patients with Alzheimer's disease | Q22252908 | ||
Cholinesterase inhibitors for Alzheimer's disease | Q22252975 | ||
“Mini-mental state” | Q25938989 | ||
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil | Q33459417 | ||
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. | Q33979412 | ||
Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease | Q35465836 | ||
Home health care utilization: a review of the research for social work | Q35903745 | ||
Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years | Q36107758 | ||
Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study | Q36903154 | ||
Community care for demented and non-demented elderly people: a comparison study of financial burden, service use, and unmet needs in family supporters | Q36903872 | ||
The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation. | Q38743854 | ||
Dementia and help with household tasks: a comparison of cases and non-cases | Q39528752 | ||
The amount of informal and formal care among non-demented and demented elderly persons-results from a Swedish population-based study. | Q40395103 | ||
Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience, part XVII. | Q40896300 | ||
Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease | Q42602615 | ||
3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy | Q42681493 | ||
Home nursing and home help for dementia patients: Predictors for utilization and expected quality from a family caregiver's point of view. | Q43593187 | ||
The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial | Q44766915 | ||
Incremental patterns in the amount of informal and formal care among non-demented and demented elderly persons: results from a 3-year follow-up population-based study | Q44962837 | ||
Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis | Q46375583 | ||
Predictors of cognitive and functional progression in patients with probable Alzheimer's disease | Q48884069 | ||
The role of cognitive status in the use of inhome services: implications for nursing assessment. | Q50155127 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Alzheimer's disease | Q11081 |
P304 | page(s) | 329-339 | |
P577 | publication date | 2013-03-20 | |
P1433 | published in | Clinical Interventions in Aging | Q5133768 |
P1476 | title | A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy | |
P478 | volume | 8 |
Q92523174 | Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease |
Q36118948 | Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death |
Q55456183 | Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease. |
Q35144642 | Donepezil and life expectancy in Alzheimer's disease: a retrospective analysis in the Tajiri Project |
Q40607418 | Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease |
Q35834150 | Lifetime expectancy and quality-adjusted life-year in Alzheimer's disease with and without cerebrovascular disease: effects of nursing home replacement and donepezil administration--a retrospective analysis in the Tajiri Project |
Q88631521 | Longitudinal changes in quality of life among elderly people with and without dementia |
Q53356856 | Measures to prevent Alzheimer's patients from discontinuing the use of cholinesterase inhibitors. |
Q35218713 | Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review |
Q37690649 | Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies |
Q36264977 | Real-world evaluation of compliance and preference in Alzheimer's disease treatment |
Q34233759 | Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease |
Q47862426 | Short-Term Response is not Predictive of Long-Term Response to Acetylcholinesterase Inhibitors in Old Age Subjects with Alzheimer's Disease: A "Real World" Study |
Q34548336 | Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services |
Q48299438 | Telephone-based Minnesota Cognitive Acuity Screen predicts time to institutionalization and homecare |
Q36072043 | The Agreement between the MMSE and IQCODE Tests in a Community-Based Sample of Subjects Aged 70 Years or Older Receiving In-Home Nursing: An Explorative Study |
Q36572028 | The impact of dementia on the use of general practitioners among the elderly in Norway |
Search more.